About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Rheumatoid Arthritis Market Size to Strike US$104.5 billion by 2032
Rheumatoid Arthritis Market

Rheumatoid Arthritis Market Size, Share & Trends Analysis Report By Drug Class (Disease-modifying Antirheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Uric Acid Drugs), By Route of Administration (Oral, Parental), By Sales Channel (Prescription-based Drugs, Over-the-counter Drugs) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI55846DR
Last Updated : Jul 08, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Rheumatoid Arthritis Market, By Drug Class (2020-2032)
    1. Disease-modifying Antirheumatic Drugs (DMARDs)
    2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    3. Corticosteroids
    4. Uric Acid Drugs
  2. Rheumatoid Arthritis Market, By Route of Administration (2020-2032)
    1. Oral
    2. Parental
  3. Rheumatoid Arthritis Market, By Sales Channel (2020-2032)
    1. Prescription-based Drugs
    2. Over-the-counter Drugs
    1. North America
      1. North America Rheumatoid Arthritis Market, By Drug Class
        1. Disease-modifying Antirheumatic Drugs (DMARDs)
          1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
            1. Corticosteroids
              1. Uric Acid Drugs
              2. North America Rheumatoid Arthritis Market, By Route of Administration
                1. Oral
                  1. Parental
                  2. North America Rheumatoid Arthritis Market, By Sales Channel
                    1. Prescription-based Drugs
                      1. Over-the-counter Drugs
                      2. U.S.
                        1. U.S. Rheumatoid Arthritis Market, By Drug Class
                          1. Disease-modifying Antirheumatic Drugs (DMARDs)
                            1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                              1. Corticosteroids
                                1. Uric Acid Drugs
                                2. U.S. Rheumatoid Arthritis Market, By Route of Administration
                                  1. Oral
                                    1. Parental
                                    2. U.S. Rheumatoid Arthritis Market, By Sales Channel
                                      1. Prescription-based Drugs
                                        1. Over-the-counter Drugs
                                      2. Canada
                                    3. Europe
                                      1. Europe Rheumatoid Arthritis Market, By Drug Class
                                        1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                          1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                            1. Corticosteroids
                                              1. Uric Acid Drugs
                                              2. Europe Rheumatoid Arthritis Market, By Route of Administration
                                                1. Oral
                                                  1. Parental
                                                  2. Europe Rheumatoid Arthritis Market, By Sales Channel
                                                    1. Prescription-based Drugs
                                                      1. Over-the-counter Drugs
                                                      2. U.K.
                                                        1. U.K. Rheumatoid Arthritis Market, By Drug Class
                                                          1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                                            1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                                              1. Corticosteroids
                                                                1. Uric Acid Drugs
                                                                2. U.K. Rheumatoid Arthritis Market, By Route of Administration
                                                                  1. Oral
                                                                    1. Parental
                                                                    2. U.K. Rheumatoid Arthritis Market, By Sales Channel
                                                                      1. Prescription-based Drugs
                                                                        1. Over-the-counter Drugs
                                                                      2. Germany
                                                                      3. France
                                                                      4. Spain
                                                                      5. Italy
                                                                      6. Russia
                                                                      7. Nordic
                                                                      8. Benelux
                                                                      9. Rest of Europe
                                                                    3. APAC
                                                                      1. APAC Rheumatoid Arthritis Market, By Drug Class
                                                                        1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                                                          1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                                                            1. Corticosteroids
                                                                              1. Uric Acid Drugs
                                                                              2. APAC Rheumatoid Arthritis Market, By Route of Administration
                                                                                1. Oral
                                                                                  1. Parental
                                                                                  2. APAC Rheumatoid Arthritis Market, By Sales Channel
                                                                                    1. Prescription-based Drugs
                                                                                      1. Over-the-counter Drugs
                                                                                      2. China
                                                                                        1. China Rheumatoid Arthritis Market, By Drug Class
                                                                                          1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                                                                            1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                                                                              1. Corticosteroids
                                                                                                1. Uric Acid Drugs
                                                                                                2. China Rheumatoid Arthritis Market, By Route of Administration
                                                                                                  1. Oral
                                                                                                    1. Parental
                                                                                                    2. China Rheumatoid Arthritis Market, By Sales Channel
                                                                                                      1. Prescription-based Drugs
                                                                                                        1. Over-the-counter Drugs
                                                                                                      2. Korea
                                                                                                      3. Japan
                                                                                                      4. India
                                                                                                      5. Australia
                                                                                                      6. Singapore
                                                                                                      7. Taiwan
                                                                                                      8. South East Asia
                                                                                                      9. Rest of Asia-Pacific
                                                                                                    3. Middle East and Africa
                                                                                                      1. Middle East and Africa Rheumatoid Arthritis Market, By Drug Class
                                                                                                        1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                                                                                          1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                                                                                            1. Corticosteroids
                                                                                                              1. Uric Acid Drugs
                                                                                                              2. Middle East and Africa Rheumatoid Arthritis Market, By Route of Administration
                                                                                                                1. Oral
                                                                                                                  1. Parental
                                                                                                                  2. Middle East and Africa Rheumatoid Arthritis Market, By Sales Channel
                                                                                                                    1. Prescription-based Drugs
                                                                                                                      1. Over-the-counter Drugs
                                                                                                                      2. UAE
                                                                                                                        1. UAE Rheumatoid Arthritis Market, By Drug Class
                                                                                                                          1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                                                                                                            1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                                                                                                              1. Corticosteroids
                                                                                                                                1. Uric Acid Drugs
                                                                                                                                2. UAE Rheumatoid Arthritis Market, By Route of Administration
                                                                                                                                  1. Oral
                                                                                                                                    1. Parental
                                                                                                                                    2. UAE Rheumatoid Arthritis Market, By Sales Channel
                                                                                                                                      1. Prescription-based Drugs
                                                                                                                                        1. Over-the-counter Drugs
                                                                                                                                      2. Turkey
                                                                                                                                      3. Saudi Arabia
                                                                                                                                      4. South Africa
                                                                                                                                      5. Egypt
                                                                                                                                      6. Nigeria
                                                                                                                                      7. Rest of MEA
                                                                                                                                    3. LATAM
                                                                                                                                      1. LATAM Rheumatoid Arthritis Market, By Drug Class
                                                                                                                                        1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                                                                                                                          1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                                                                                                                            1. Corticosteroids
                                                                                                                                              1. Uric Acid Drugs
                                                                                                                                              2. LATAM Rheumatoid Arthritis Market, By Route of Administration
                                                                                                                                                1. Oral
                                                                                                                                                  1. Parental
                                                                                                                                                  2. LATAM Rheumatoid Arthritis Market, By Sales Channel
                                                                                                                                                    1. Prescription-based Drugs
                                                                                                                                                      1. Over-the-counter Drugs
                                                                                                                                                      2. Brazil
                                                                                                                                                        1. Brazil Rheumatoid Arthritis Market, By Drug Class
                                                                                                                                                          1. Disease-modifying Antirheumatic Drugs (DMARDs)
                                                                                                                                                            1. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
                                                                                                                                                              1. Corticosteroids
                                                                                                                                                                1. Uric Acid Drugs
                                                                                                                                                                2. Brazil Rheumatoid Arthritis Market, By Route of Administration
                                                                                                                                                                  1. Oral
                                                                                                                                                                    1. Parental
                                                                                                                                                                    2. Brazil Rheumatoid Arthritis Market, By Sales Channel
                                                                                                                                                                      1. Prescription-based Drugs
                                                                                                                                                                        1. Over-the-counter Drugs
                                                                                                                                                                      2. Mexico
                                                                                                                                                                      3. Argentina
                                                                                                                                                                      4. Chile
                                                                                                                                                                      5. Colombia
                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                  Related Reports

                                                                                                                                                                  Global Report
                                                                                                                                                                  The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                  Buy Now
                                                                                                                                                                  Global Report
                                                                                                                                                                  The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                  Buy Now
                                                                                                                                                                  Global Report
                                                                                                                                                                  Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                  Buy Now
                                                                                                                                                                  Global Report
                                                                                                                                                                  The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                  Buy Now
                                                                                                                                                                  Global Report
                                                                                                                                                                  The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                  Buy Now

                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                  • Permission to print the report

                                                                                                                                                                  We are featured on :

                                                                                                                                                                  www.straitsresearch.com
                                                                                                                                                                  © Copyright . All rights Reserved.